These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 9722064)
21. Primitive hematopoietic progenitor cells are present in peripheral blood autografts. Tong J; Gianni AM; Siena S; Srour EF; Bregni M; Hoffman R Blood Cells; 1994; 20(2-3):351-62; discussion 362-3. PubMed ID: 7538339 [TBL] [Abstract][Full Text] [Related]
22. Phenotypic analysis of early hematopoietic progenitors in cord blood and determination of their correlation with clonogenic progenitors: relevance to cord blood stem cell transplantation. Payne TA; Traycoff CM; Laver J; Xu F; Srour EF; Abboud MR Bone Marrow Transplant; 1995 Feb; 15(2):187-92. PubMed ID: 7539665 [TBL] [Abstract][Full Text] [Related]
23. Phenotype and progeny of primitive adherent human hematopoietic progenitors. Gordon MY; Lewis JL; Grand FH; Marley SB; Goldman JM Leukemia; 1996 Aug; 10(8):1347-53. PubMed ID: 8709641 [TBL] [Abstract][Full Text] [Related]
25. Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers. Huhn RD; Yurkow EJ; Tushinski R; Clarke L; Sturgill MG; Hoffman R; Sheay W; Cody R; Philipp C; Resta D; George M Exp Hematol; 1996 Jun; 24(7):839-47. PubMed ID: 8647235 [TBL] [Abstract][Full Text] [Related]
26. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor. Watanabe H; Watanabe T; Suzuya H; Wakata Y; Kaneko M; Onishi T; Okamoto Y; Abe T; Kawano Y; Kagami S; Takaue Y Bone Marrow Transplant; 2006 Apr; 37(7):661-8. PubMed ID: 16489358 [TBL] [Abstract][Full Text] [Related]
27. T cell alloreactivity induced by normal G-CSF-mobilized CD34+ blood cells. Rondelli D; Anasetti C; Fortuna A; Ratta M; Arpinati M; Bandini G; Lemoli RM; Tura S Bone Marrow Transplant; 1998 Jun; 21(12):1183-91. PubMed ID: 9674849 [TBL] [Abstract][Full Text] [Related]
28. Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation. Matsunaga T; Sakamaki S; Kohgo Y; Ohi S; Hirayama Y; Niitsu Y Bone Marrow Transplant; 1993 Feb; 11(2):103-8. PubMed ID: 7679596 [TBL] [Abstract][Full Text] [Related]
29. Differential regulation of the expression of CD38 and human leukocyte antigen-DR on CD34+ hematopoietic progenitor cells by interleukin-4 and interferon-gamma. Snoeck HW; Lardon F; Lenjou M; Nys G; Van Bockstaele DR; Peetermans ME Exp Hematol; 1993 Oct; 21(11):1480-6. PubMed ID: 7691636 [TBL] [Abstract][Full Text] [Related]
30. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells. Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558 [TBL] [Abstract][Full Text] [Related]
31. Role of the CD34+ 38- cells in posttransplant hematopoietic recovery. Hénon P; Sovalat H; Bourderont D; Ojeda-Uribe M; Arkam Y; Wunder E; Raidot JP; Husseini F; Audhuy B Stem Cells; 1998; 16 Suppl 1():113-22. PubMed ID: 11012153 [TBL] [Abstract][Full Text] [Related]
32. Distinct alterations in lineage committed progenitor cells exist in the peripheral blood of patients with rheumatoid arthritis and primary Sjogren's syndrome. Santiago-Schwarz F; Sullivan C; Rappa D; Carsons SE J Rheumatol; 1996 Mar; 23(3):439-46. PubMed ID: 8832979 [TBL] [Abstract][Full Text] [Related]
33. Mobilization of peripheral blood progenitor cells by Betafectin PGG-Glucan alone and in combination with granulocyte colony-stimulating factor. Patchen ML; Liang J; Vaudrain T; Martin T; Melican D; Zhong S; Stewart M; Quesenberry PJ Stem Cells; 1998; 16(3):208-17. PubMed ID: 9617896 [TBL] [Abstract][Full Text] [Related]
34. Hematopoietic progenitor cells from allogeneic bone marrow transplant donors circulate in the very early post-transplant period. Katayama Y; Mahmut N; Takimoto H; Maeda Y; Yano T; Kojima K; Azuma T; Hara M; Imajyo K; Takahashi S; Kai T; Ohno Y; Miyamoto T; Nagafuji K; Matsue K; Takenaka K; Teshima T; Shinagawa K; Ishimaru F; Omoto E; Harada M Bone Marrow Transplant; 1999 Apr; 23(7):659-65. PubMed ID: 10218841 [TBL] [Abstract][Full Text] [Related]
35. A time course study for optimal harvest of peripheral blood progenitor cells by granulocyte colony-stimulating factor in healthy volunteers. Sato N; Sawada K; Takahashi TA; Mogi Y; Asano S; Koike T; Sekiguchi S Exp Hematol; 1994 Sep; 22(10):973-8. PubMed ID: 7522184 [TBL] [Abstract][Full Text] [Related]
36. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation. Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046 [TBL] [Abstract][Full Text] [Related]
37. Importance of CD34+ cell subsets in autologous PBSC transplantation: the mulhouse experience using CD34+CD38- cells as predictive tool for hematopoietic engraftment. Hénon PH; Sovalat H; Bourderont D J Biol Regul Homeost Agents; 2001; 15(1):62-7. PubMed ID: 11388746 [TBL] [Abstract][Full Text] [Related]
38. High efficiency electroporation of human umbilical cord blood CD34+ hematopoietic precursor cells. Wu MH; Smith SL; Dolan ME Stem Cells; 2001; 19(6):492-9. PubMed ID: 11713340 [TBL] [Abstract][Full Text] [Related]
39. Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor. Lorenzon D; Mazzucato M; Abbruzzese L; Cilli M; De Angeli S; Degan M; Mambrini G; Piccardi F; Rupolo M; Michieli M; De Marco L; Gattei V; Astori G Vox Sang; 2008 May; 94(4):342-50. PubMed ID: 18282263 [TBL] [Abstract][Full Text] [Related]
40. Stem cell mobilization with G-CSF alone in breast cancer patients: higher progenitor cell yield by delivering divided doses (2 x 5 microg/kg) compared to a single dose (1 x 10 microg/kg). Kröger N; Zeller W; Hassan HT; Krüger W; Gutensohn K; Löliger C; Zander AR Bone Marrow Transplant; 1999 Jan; 23(2):125-9. PubMed ID: 10197796 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]